BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Troisi J, Belmonte F, Bisogno A, Pierri L, Colucci A, Scala G, Cavallo P, Mandato C, Di Nuzzi A, Di Michele L, Delli Bovi AP, Guercio Nuzio S, Vajro P. Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome. Nutrients 2019;11:E274. [PMID: 30691143 DOI: 10.3390/nu11020274] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Grootveld M, Page G, Bhogadia M, Edgar M. Updates and Original Case Studies Focused on the NMR-Linked Metabolomics Analysis of Human Oral Fluids Part I: Emerging Platforms and Perspectives. Applied Sciences 2022;12:1235. [DOI: 10.3390/app12031235] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Payab M, Tayanloo-beik A, Falahzadeh K, Mousavi M, Salehi S, Djalalinia S, Ebrahimpur M, Rezaei N, Rezaei-tavirani M, Larijani B, Arjmand B, Gilany K. Metabolomics prospect of obesity and metabolic syndrome; a systematic review. J Diabetes Metab Disord. [DOI: 10.1007/s40200-021-00917-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Handakas E, Lau CH, Alfano R, Chatzi VL, Plusquin M, Vineis P, Robinson O. A systematic review of metabolomic studies of childhood obesity: State of the evidence for metabolic determinants and consequences. Obes Rev 2021;:e13384. [PMID: 34797026 DOI: 10.1111/obr.13384] [Reference Citation Analysis]
4 De Spiegeleer M, De Paepe E, Van Meulebroek L, Gies I, De Schepper J, Vanhaecke L. Paediatric obesity: a systematic review and pathway mapping of metabolic alterations underlying early disease processes. Mol Med 2021;27:145. [PMID: 34742239 DOI: 10.1186/s10020-021-00394-0] [Reference Citation Analysis]
5 Piras C, Noto A, Ibba L, Deidda M, Fanos V, Muntoni S, Leoni VP, Atzori L. Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review. Metabolites 2021;11:694. [PMID: 34677409 DOI: 10.3390/metabo11100694] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
6 Colucci A, Rocco MC, De Anseris AGE, Nazzaro L, Vajro P, Mandato C. Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path. Exploration of Medicine. [DOI: 10.37349/emed.2021.00051] [Reference Citation Analysis]
7 Chen B, Pan CQ. Non-Invasive Assessment of Fibrosis and Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease. Clin Res Hepatol Gastroenterol 2021;:101755. [PMID: 34311134 DOI: 10.1016/j.clinre.2021.101755] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wu XM, Yang X, Fan XC, Chen X, Wang YX, Zhang LX, Song JK, Zhao GH. Serum metabolomics in chickens infected with Cryptosporidium baileyi. Parasit Vectors 2021;14:336. [PMID: 34174965 DOI: 10.1186/s13071-021-04834-y] [Reference Citation Analysis]
9 Norrman AE, Tervahartiala T, Sahlberg E, Sorsa T, Ruokonen H, Grönroos L, Meurman JH, Isoniemi H, Nordin A, Åberg F, Helenius-Hietala J. Salivary Biomarkers and Oral Health in Liver Transplant Recipients, with an Emphasis on Diabetes. Diagnostics (Basel) 2021;11:662. [PMID: 33916950 DOI: 10.3390/diagnostics11040662] [Reference Citation Analysis]
10 Masarone M, Troisi J, Aglitti A, Torre P, Colucci A, Dallio M, Federico A, Balsano C, Persico M. Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis. Metabolomics 2021;17:12. [PMID: 33458794 DOI: 10.1007/s11306-020-01756-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Petrick LM, Arora M, Niedzwiecki MM. Minimally Invasive Biospecimen Collection for Exposome Research in Children's Health. Curr Environ Health Rep 2020;7:198-210. [PMID: 32535858 DOI: 10.1007/s40572-020-00277-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Lemieux I, Després JP. Metabolic Syndrome: Past, Present and Future. Nutrients 2020;12:E3501. [PMID: 33202550 DOI: 10.3390/nu12113501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Cialiè Rosso M, Stilo F, Squara S, Liberto E, Mai S, Mele C, Marzullo P, Aimaretti G, Reichenbach SE, Collino M, Bicchi C, Cordero C. Exploring extra dimensions to capture saliva metabolite fingerprints from metabolically healthy and unhealthy obese patients by comprehensive two-dimensional gas chromatography featuring Tandem Ionization mass spectrometry. Anal Bioanal Chem 2021;413:403-18. [PMID: 33140127 DOI: 10.1007/s00216-020-03008-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Liu Z, Zhu H, Wang W, Xu J, Que S, Zhuang L, Qian J, Wang S, Yu J, Zhang F, Yin S, Xie H, Zhou L, Geng L, Zheng S. Metabonomic Profile of Macrosteatotic Allografts for Orthotopic Liver Transplantation in Patients With Initial Poor Function: Mechanistic Investigation and Prognostic Prediction. Front Cell Dev Biol 2020;8:826. [PMID: 32984324 DOI: 10.3389/fcell.2020.00826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Vilar-Gomez E, Sookoian S, Pirola CJ, Liang T, Gawrieh S, Cummings O, Liu W, Chalasani NP. ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption. Gastroenterology 2020;159:929-43. [PMID: 32454036 DOI: 10.1053/j.gastro.2020.05.054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wijnant K, Van Meulebroek L, Pomian B, De Windt K, De Henauw S, Michels N, Vanhaecke L. Validated Ultra-High-Performance Liquid Chromatography Hybrid High-Resolution Mass Spectrometry and Laser-Assisted Rapid Evaporative Ionization Mass Spectrometry for Salivary Metabolomics. Anal Chem 2020;92:5116-24. [PMID: 32150679 DOI: 10.1021/acs.analchem.9b05598] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Beyoğlu D, Idle JR. Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy. Metabolites 2020;10:E50. [PMID: 32012846 DOI: 10.3390/metabo10020050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
18 Gardner A, Carpenter G, So PW. Salivary Metabolomics: From Diagnostic Biomarker Discovery to Investigating Biological Function. Metabolites 2020;10:E47. [PMID: 31991929 DOI: 10.3390/metabo10020047] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
19 Di Sessa A, Cirillo G, Guarino S, Marzuillo P, Miraglia Del Giudice E. Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management. Pediatric Health Med Ther 2019;10:89-97. [PMID: 31692530 DOI: 10.2147/PHMT.S188989] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
20 D'Adamo E, Castorani V, Nobili V. The Liver in Children With Metabolic Syndrome. Front Endocrinol (Lausanne) 2019;10:514. [PMID: 31428049 DOI: 10.3389/fendo.2019.00514] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]